CN106727246A - Calf serum cell nutrient solution - Google Patents
Calf serum cell nutrient solution Download PDFInfo
- Publication number
- CN106727246A CN106727246A CN201710069327.8A CN201710069327A CN106727246A CN 106727246 A CN106727246 A CN 106727246A CN 201710069327 A CN201710069327 A CN 201710069327A CN 106727246 A CN106727246 A CN 106727246A
- Authority
- CN
- China
- Prior art keywords
- calf serum
- nutrient solution
- growth factor
- hyaluronic acid
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
The present invention provides a kind of calf serum cell nutrient solution, including calf serum, epithelical cell growth factor and hyaluronic acid；The percent by volume of each composition is：Calf serum：70 95%；Epithelical cell growth factor：1 10%；Hyaluronic acid：1 30%.After the technical program, arranged in pairs or groups by the reasonable combination of three of the above composition, comprehensive maintenance and regulation scientifically is carried out in face of cell from cytotrophy, growth, reparation tripartite in process of tissue reparation, shortening repair time is reached, accelerates the purpose of skin repair.
Description
Technical field
The present invention relates to repair class cosmetic field, more particularly to a kind of calf serum cell nutrient solution.
Background technology
The existing main component for repairing product is epithelical cell growth factor, and epithelical cell growth factor is to promoting into fiber
The metabolism of cell and the formation of collagen play critical function, can promote the growth and breeding of skin histology, on regulation and control skin
The division of skin, endothelium and stroma cell, breeding and Growth and Differentiation, promote cell metabolism and growth.
Because epithelical cell growth factor single can only play a part of cell growth, therefore user is produced using such reparation
Product find following problem using process：1st, the cycle repaired and grow is relatively long.2nd, nutritional ingredient is single, and limitation is larger,
Various demands of user can not be met.
The content of the invention
In order to solve the deficiency of prior art presence, the present invention provides a kind of polynary nutritional ingredient, reparation and growth cycle
Relatively short calf serum cell nutrient solution.
To achieve these goals, the technical scheme of present invention offer is：A kind of calf serum cell nutrient solution, including it is small
Cow's serum, epithelical cell growth factor and hyaluronic acid；The percent by volume of each composition is：Calf serum：70-95%；Epidermis
Porcine HGF：1-10%；Hyaluronic acid：1-30%.
After the technical program, calf serum：Rich in 70% inorganic substances, such as electrolyte and various necessary micro units
Element, and 30% organic substance, such as oligosaccharides, nucleic acid derivative, amino acid, low molecular polypeptide, glycolipid class and sugar and lipid metabolism
Intermediate product etc., by promoting intake and utilization of the cell to glucose, increase intake and utilization of the cell to supporting so that
Atriphos generation increases, and improves cellular energy, increases with energy requirement in the case where function defect, metabolism are suppressed
When, promote cellular energy metabolism, improvement cell function, enhancing repair in cellular level.
Hyaluronic acid：It is a kind of high molecular polymer, is shown in body with its unique molecular structure and physicochemical property
Regulatory protein matter, Water-Electrolyte diffusion and operating are shown, promote wound healing etc., it is most important that sodium hyaluronate has special guarantor
Water is acted on, and water is the source of all things on earth, and the distinctive water retaining function of hyaluronic acid plays vital effect during cell repair.
By three of the above reasonable composition combine arrange in pairs or groups, calf serum cell nutrient solution in process of tissue reparation scientifically
Comprehensive maintenance and regulation is carried out in face of cell from cytotrophy, growth, reparation tripartite, shortening repair time is reached, accelerated
The purpose of skin repair.
Specific embodiment
Preferred embodiments of the present invention are further elaborated below：
Implementation method one
A kind of calf serum cell nutrient solution, including calf serum, epithelical cell growth factor and hyaluronic acid；Each composition
Percent by volume be：Calf serum：82%；Epithelical cell growth factor：6%；Hyaluronic acid：12%.
Implementation method two
A kind of calf serum cell nutrient solution, including calf serum, epithelical cell growth factor and hyaluronic acid；Each composition
Percent by volume be：Calf serum：70%；Epithelical cell growth factor：1%；Hyaluronic acid：29%.
Implementation method three
A kind of calf serum cell nutrient solution, including calf serum, epithelical cell growth factor and hyaluronic acid；Each composition
Percent by volume be：Calf serum：95%；Epithelical cell growth factor：3%；Hyaluronic acid：7%.
Implementation method four
A kind of calf serum cell nutrient solution, including calf serum, epithelical cell growth factor and hyaluronic acid；Each composition
Percent by volume be：Calf serum：80%；Epithelical cell growth factor：7%；Hyaluronic acid：13%.
Implementation method five
A kind of calf serum cell nutrient solution, including calf serum, epithelical cell growth factor and hyaluronic acid；Each composition
Percent by volume be：Calf serum：85%；Epithelical cell growth factor：4%；Hyaluronic acid：11%.
In order to fully demonstrate technical scheme and other reparation class differences and superiority, patient 900 is now chosen
Clinical data, at 18-50 Sui, the surface of a wound is located at 480, face to patient age, four limbs 250, trunk 170, the surface of a wound to spread or
The sheet of aggregation is distributed, and area is：2.5 X of X 1.0cm to 5.0 3.0cm differ in size.
Note：Surface of a wound area X before surface of a wound relaxation shrinkage (%)=(surface of a wound area after surface of a wound area-medication before medication)/medication
100%.
The present invention is not limited to above-mentioned preferred forms, and anyone can show that other are various under enlightenment of the invention
The product of form, however, make any change in its shape or structure, it is every with skill identical or similar to the present application
Art scheme, is within the scope of the present invention.
Claims (3)
1. a kind of calf serum cell nutrient solution, it is characterised in that：Including calf serum, epithelical cell growth factor and hyalomitome
Acid；The percent by volume of each composition is：Calf serum：70-95%；Epithelical cell growth factor：1-10%；Hyaluronic acid：1-
30%.
2. calf serum cell nutrient solution according to claim 1, it is characterised in that：The percent by volume of each composition is：
Calf serum：80-85%；Epithelical cell growth factor：4-7%；Hyaluronic acid：10-20%.
3. calf serum cell nutrient solution according to claim 2, it is characterised in that：The percent by volume of each composition is：
Calf serum：82%；Epithelical cell growth factor：6%；Hyaluronic acid：12%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710069327.8A CN106727246A (en) | 2017-02-08 | 2017-02-08 | Calf serum cell nutrient solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710069327.8A CN106727246A (en) | 2017-02-08 | 2017-02-08 | Calf serum cell nutrient solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106727246A true CN106727246A (en) | 2017-05-31 |
Family
ID=58956351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710069327.8A Pending CN106727246A (en) | 2017-02-08 | 2017-02-08 | Calf serum cell nutrient solution |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106727246A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108635569A (en) * | 2018-06-14 | 2018-10-12 | 天津市正江现代生物技术有限公司 | A kind of small Swine serum cell nutrient solution |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN85102921A (en) * | 1985-04-05 | 1986-10-08 | 菲地亚有限公司 | Preparation has pharmaceutically-active hyaluronic acid component and contains the method for the medicine of this component |
| CN1335135A (en) * | 2000-07-25 | 2002-02-13 | 凌沛学 | Artificial skin powder prepn containing sodium hyaluronate and its prepn |
| CN1337270A (en) * | 2000-08-07 | 2002-02-27 | 黄玲惠 | Wound dressing and its prepn. |
| CN1586457A (en) * | 2004-07-09 | 2005-03-02 | 何玉兰 | Compound active biological factor beauty liquid |
| CN1640491A (en) * | 2004-01-15 | 2005-07-20 | 方昌阁 | Recombinant human epidermal growth factor compound biological agent and its use |
| CN1676602A (en) * | 2004-04-02 | 2005-10-05 | 天津市天津医院 | Skin cell with anti-inflammatory activity, and its preparing method and use for skin infective wound surface |
| CN1800372A (en) * | 2005-12-02 | 2006-07-12 | 王平安 | Engineered extracellular matrix preparation method |
| CN1939288A (en) * | 2006-08-10 | 2007-04-04 | 河北医科大学口腔医院 | Composite acne-inhibiting pellicle |
| CN102839205A (en) * | 2012-08-21 | 2012-12-26 | 任杰 | Method for preparing oligopeptide epidermis cell growth factor dry powder |
| CN102861320A (en) * | 2011-07-08 | 2013-01-09 | 上海昊海生物科技股份有限公司 | Spray for treating skin and mucosa wounds |
| CN104840428A (en) * | 2014-02-13 | 2015-08-19 | 山东省生物医药科学院 | Hyaluronic acid-chitosan microsphere carrying epidermal growth factor and preparation method and application of hyaluronic acid-chitosan microsphere |
-
2017
- 2017-02-08 CN CN201710069327.8A patent/CN106727246A/en active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN85102921A (en) * | 1985-04-05 | 1986-10-08 | 菲地亚有限公司 | Preparation has pharmaceutically-active hyaluronic acid component and contains the method for the medicine of this component |
| CN1335135A (en) * | 2000-07-25 | 2002-02-13 | 凌沛学 | Artificial skin powder prepn containing sodium hyaluronate and its prepn |
| CN1337270A (en) * | 2000-08-07 | 2002-02-27 | 黄玲惠 | Wound dressing and its prepn. |
| CN1640491A (en) * | 2004-01-15 | 2005-07-20 | 方昌阁 | Recombinant human epidermal growth factor compound biological agent and its use |
| CN1676602A (en) * | 2004-04-02 | 2005-10-05 | 天津市天津医院 | Skin cell with anti-inflammatory activity, and its preparing method and use for skin infective wound surface |
| CN1586457A (en) * | 2004-07-09 | 2005-03-02 | 何玉兰 | Compound active biological factor beauty liquid |
| CN1800372A (en) * | 2005-12-02 | 2006-07-12 | 王平安 | Engineered extracellular matrix preparation method |
| CN1939288A (en) * | 2006-08-10 | 2007-04-04 | 河北医科大学口腔医院 | Composite acne-inhibiting pellicle |
| CN102861320A (en) * | 2011-07-08 | 2013-01-09 | 上海昊海生物科技股份有限公司 | Spray for treating skin and mucosa wounds |
| CN102839205A (en) * | 2012-08-21 | 2012-12-26 | 任杰 | Method for preparing oligopeptide epidermis cell growth factor dry powder |
| CN104840428A (en) * | 2014-02-13 | 2015-08-19 | 山东省生物医药科学院 | Hyaluronic acid-chitosan microsphere carrying epidermal growth factor and preparation method and application of hyaluronic acid-chitosan microsphere |
Non-Patent Citations (1)
| Title |
|---|
| 张瑶华等: "《中国常用药品集》", 30 June 2006, 上海交通大学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108635569A (en) * | 2018-06-14 | 2018-10-12 | 天津市正江现代生物技术有限公司 | A kind of small Swine serum cell nutrient solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071191A (en) | Preparation method of autologous platelet-factor-rich plasma (PFRP) preparation | |
| ES2119250T3 (en) | COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND DIFFERENTIATION OF MEGACARIOCITOS. | |
| RU2016119532A (en) | PRODUCTION OF RECOMBINANT LUBRICIN | |
| CN105832613A (en) | All-effect repair water-optical skin-rejuvenating lotion | |
| Moisenovich et al. | Novel 3D-microcarriers from recombinant spidroin for regenerative medicine | |
| CN101037666A (en) | Low temperature preservation solution for animal cells and preserving method | |
| CN107137340A (en) | Reparation facial mask of the secretion activity factor of human mesenchymal stem cell containing high concentration and preparation method thereof | |
| CN109731126A (en) | A kind of biological dressing and preparation method thereof with reparation skin function | |
| Hwang et al. | An effective range of polydeoxyribonucleotides is critical for wound healing quality | |
| CN108743921A (en) | It is a kind of to prevent the reparation liquid and its preparation method and application that scar is formed | |
| CN106727246A (en) | Calf serum cell nutrient solution | |
| CN105749333A (en) | Medical dressing of hyaluronic acid and preparation method of medical dressing | |
| CN103462865B (en) | Embryo water extract extracted from animal embryo skin and muscle, and extraction method and applications thereof | |
| CN103386145A (en) | Wound healing dressing containing carrageenan, and preparation method and application of wound healing dressing | |
| CN108744024A (en) | It is a kind of to compound anti-scar liquor biological dressing and preparation method thereof | |
| CN109864964B (en) | Anti-aging composition containing stem cells and application thereof | |
| CN1868422A (en) | Method for preparing artificial skin used for reparing skin defect | |
| PH12017550132A1 (en) | Beta-casein a2 and antioxidant capacity | |
| CN109999185B (en) | Composition for repairing damage and preparation method and application thereof | |
| CN108578617B (en) | Preparation method of umbilical cord blood mesenchymal stem cell medicine for promoting regeneration of knee joint cartilage | |
| CN106309172A (en) | Anti-aging eye essence liquid containing biological compound peptide | |
| CN107854730A (en) | It is crosslinked the preparation method and applications of CGA sodium alginate gelatin cross-blend syndesis sticking patch | |
| CN108719541A (en) | A kind of tea of the U.S. breast of chest enlarge | |
| CN108686260B (en) | Preparation method of compound scar-proof emulsion biological dressing | |
| CN108635569A (en) | A kind of small Swine serum cell nutrient solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Xu Bing Inventor before: Xu Bing Inventor before: Zhou Guoyu |
|
| CB03 | Change of inventor or designer information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |
|
| RJ01 | Rejection of invention patent application after publication |